Anthem Biosciences (NSE:ANTHEM) Institutional Ownership: 12.97% (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ANTHEM Anthem Biosciences Ltd NSE:ANTHEM
24 GF Score
Price ₹933.50
! 7 Warning Signs
View Full Analysis

What is Anthem Biosciences Institutional Ownership?

Anthem Biosciences NSE:ANTHEM -0.06% 24 Institutional Ownership is 12.97% as of Sep. 08, 2026. GuruFocus rates NSE:ANTHEM with a GF Score™ of 24/100. The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Anthem Biosciences's institutional ownership is 12.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Anthem Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Anthem Biosciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Anthem Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Anthem Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthem Biosciences Institutional Ownership Chart

Anthem Biosciences Historical Data

The historical data trend for Anthem Biosciences can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 7.88 7.98 8.25 8.46 11.79 11.70 11.84 14.08 12.96 12.97
NSE:ANTHEM
24GF Score
Anthem Biosciences Ltd NSE:ANTHEM
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anthem Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 12.97% mean?
Anthem Biosciences (NSE:ANTHEM) has a Institutional Ownership of 12.97% as of Sep. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Anthem Biosciences and its competitors.
Is Anthem Biosciences' Institutional Ownership too high?
Anthem Biosciences' current Institutional Ownership is 12.97%. Overall, Anthem Biosciences has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' Institutional Ownership compare to VRTX and REGN?
Anthem Biosciences' Institutional Ownership of 12.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Anthem Biosciences and its competitors. Anthem Biosciences's current Institutional Ownership is 12.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current Institutional Ownership of 12.97%. The current Institutional Ownership is 12.97%. Anthem Biosciences' overall GF Score™ is 24/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current Institutional Ownership is 12.97% as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anthem Biosciences Business Description

Other Exchanges 544449:India
Address No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bangalore, KA, IND, 560 099
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
24GF Score

Get the complete analysis for NSE:ANTHEM

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹933.50
Price